异常大脑MRI发现在一个治疗反应良好的抗IgLON5疾病患者中
Moein Zandiehvakili1, Cathy Kexin Cui2, Bronte Jeffrey3,4
1Department of Radiology, Westmead hospital, Sydney, Australia.
Radiology case reports
|April 22, 2024
概括
抗免疫球蛋白轻链5 (IgLON5) 疾病是一种罕见的自身免疫神经系统疾病. 这个案例突出了独特的脑部MRI发现和成功的治疗结果,为这种情况提供了新的见解.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 放射学 放射学是指放射学
背景情况:
- 抗免疫球蛋白轻链5 (IgLON5) 疾病是最近发现的一种自身免疫神经系统疾病.
- 临床表现不同,通常与正常大脑磁共振成像 (MRI) 发现有关.
- 本报告详细介绍了一个独特的案例,具有明显的MRI特征.
研究的目的:
- 描述一种具有异常脑部MRI特征的Anti-IgLON5疾病的新型病例.
- 记录免疫治疗的临床和放射性反应.
主要方法:
- 一个61岁的女性患者的病例报告.
- 临床评估和后续行动.
- 在治疗前和治疗后进行脑部MRI分析.
主要成果:
- 患者呈现出独特的大脑MRI发现,此前在Anti-IgLON5疾病中没有报道过.
- 免疫疗法导致显著的临床改善.
- 随访成像显示了相应的放射性改善.
结论:
- 这一案例扩大了Anti-IgLON5疾病已知的放射性表现的范围.
- 免疫疗法在管理临床和放射学的方面显得有效.
- 需要进一步的研究,以了解独特的MRI发现,并优化治疗策略.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...